FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernadette Mannaerts

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Fertilizations in Vitro

Physiology

Pregnancy

Anatomy

Concepts & Ideas

Pregnancy Outcomes

Disorders

Hypogonadism

Co-author Network

Publications

TOP 3
Basil C Tarlatzis; Luk Rombauts; Georg Griesinger; Pieta C Ijzerman-Boon; Arthur Leader; Bernadette M J L Mannaerts
Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
William L Ledger; Paul Devroey; Bart CJM Fauser; Anthe S Zandvliet; Bernadette M J L Mannaerts
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response.
Bart CJM Fauser; Michael M Alper; William Ledger; William B Schoolcraft; Anthe Zandvliet; Bernadette M J L Mannaerts
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernadette Mannaerts (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Basil C Tarlatzis; Luk Rombauts; Georg Griesinger; Pieta C Ijzerman-Boon; Arthur Leader; Bernadette M J L Mannaerts
Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
Reproductive biomedicine online 2012;24(4):410-9.
2011: William L Ledger; Paul Devroey; Bart CJM Fauser; Anthe S Zandvliet; Bernadette M J L Mannaerts
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response.
Reproductive biomedicine online 2011;23(2):150-9.
2011: Bart CJM Fauser; Michael M Alper; William Ledger; William B Schoolcraft; Anthe Zandvliet; Bernadette M J L Mannaerts
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
Reproductive biomedicine online 2011;22 Suppl 1():S23-31.
2010: Bart CJM Fauser; Michael M Alper; William Ledger; William B Schoolcraft; Anthe Zandvliet; Bernadette M J L Mannaerts
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
Reproductive biomedicine online 2010;21(5):593-601.
2005: Femke P Hohmann; Joop S E Laven; Annemarie G M G J Mulders; J J L Oberyé; Bernadette M J L Mannaerts; Frank de Jong; Bart CJM Fauser
LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome.
Journal of endocrinological investigation 2005;28(11):990-7.
2005: C Simon; J J L Oberyé; José Bellver; C Vidal; Ernesto Bosch; JOSE HORCAJADAS; C Murphy; S Adams; Anne Riesewijk; Bernadette M J L Mannaerts; Antonio Pellicer
Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles.
Human reproduction (Oxford, England) 2005;20(12):3318-27.
2005: Keith Gordon; John W M Mulders; Eric van Hooren; Henno W van den Hooven; Björn J Oddens; Frans Verbon; Bernadette M J L Mannaerts
Consistency of gonadotrophin products--further comment.
Reproductive biomedicine online 2005;11(3):392; author reply 393.
2005: Keith Gordon; John W M Mulders; Eric van Hooren; Henno W van den Hooven; Björn J Oddens; Bernadette M J L Mannaerts
Consistency of gonadotrophin products.
Reproductive biomedicine online 2005;11(1):115-6; author reply 117-8.
2004: Adam H Balen; Annemarie G M G J Mulders; Bart CJM Fauser; B C Schoot; M A Renier; Paul Devroey; M J Struijs; Bernadette M J L Mannaerts
Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
The Journal of clinical endocrinology and metabolism 2004;89(12):6297-304.
2002: Peter J Boerrigter; Joris J De Bie; Bernadette M J L Mannaerts; Bert P van Leeuwen; Dorrie P J Passier-Timmermans
Obstetrical and neonatal outcome after controlled ovarian stimulation for IVF using the GnRH antagonist ganirelix.
Human reproduction (Oxford, England) 2002;17(8):2027-34.
2002: Henk J Out; Bernadette M J L Mannaerts
The gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data.
Human fertility (Cambridge, England) 2002;5(1):G5-10; discussion G10-2, G41-8.
2001: Bernadette M J L Mannaerts; E van Hooren; P Boerrigter
Subgroup analyses in Orgalutran trials.
Human reproduction (Oxford, England) 2001;16(12):2726.
2001: Diederick de Jong; Nicholas S Macklon; Marinus Eijkemans; Bernadette M J L Mannaerts; Herjan J T Coelingh Bennink; Bart CJM Fauser
Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
Fertility and sterility 2001;75(4):688-93.
2001: Diederick de Jong; Eric van Hooren; Nicholas S Macklon; Bernadette M J L Mannaerts; Bart CJM Fauser
Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report.
Journal of assisted reproduction and genetics 2001;18(1):30-3.
2000: Bernadette M J L Mannaerts; K Gordon
Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor.
Human reproduction (Oxford, England) 2000;15(9):1882-3.
2000: G Voortman; Bernadette M J L Mannaerts; Johannes A M Huisman
A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*/Puregon) in healthy female volunteers.
Fertility and sterility 2000;73(6):1187-93.
2000: J J L Oberyé; Bernadette M J L Mannaerts; Johannes A M Huisman; Cees J Timmer
Local tolerance, pharmacokinetics, and dynamics of ganirelix (Orgalutran) administration by Medi-Jector compared to conventional needle injections.
Human reproduction (Oxford, England) 2000;15(2):245-9.
1999: J J L Oberyé; Bernadette M J L Mannaerts; Johannes A M Huisman; Cees J Timmer
Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers.
Fertility and sterility 1999;72(6):1006-12.
1999: J J L Oberyé; Bernadette M J L Mannaerts; H J Kleijn; Cees J Timmer
Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers.
Fertility and sterility 1999;72(6):1001-5.
1998: Diederick de Jong; Nicholas S Macklon; Bernadette M J L Mannaerts; Herjan J T Coelingh Bennink; Bart CJM Fauser
High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization.
Human reproduction (Oxford, England) 1998;13(3):573-5.
1997: Henk J Out; S G Driessen; Bernadette M J L Mannaerts; Herjan J T Coelingh Bennink
Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins.
Fertility and sterility 1997;68(1):138-42.
1996: Henk J Out; Bernadette M J L Mannaerts; S G Driessen; H J Coelingh Bennink
Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies.
Human reproduction update 1996;2(2):162-71.
1996: Bernadette M J L Mannaerts; F Rombout; Henk J Out; H Coelingh Bennink
Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy.
Human reproduction update 1996;2(2):153-61.
1996: Bernadette M J L Mannaerts; Bart CJM Fauser; N Lahlou; J Harlin; Zeev Shoham; H C Bennink; P Bouchard
Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.
Fertility and sterility 1996;65(2):406-10.
1995: Henk J Out; Bernadette M J L Mannaerts; S G Driessen; H J Bennink
A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.
Human reproduction (Oxford, England) 1995;10(10):2534-40.
1995: Paul Devroey; K Tjandraprawira; Bernadette M J L Mannaerts; H Coelingh Bennink; Johan Smitz; Maryse Bonduelle; A De Brabanter; André Van Steirteghem
A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization.
Human reproduction (Oxford, England) 1995;10(2):332-7.
1994: D C Schoot; J Harlin; Zeev Shoham; Bernadette M J L Mannaerts; N Lahlou; P Bouchard; H J Bennink; Bart CJM Fauser
Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.
Human reproduction (Oxford, England) 1994;9(7):1237-42.
1994: Paul Devroey; Bernadette M J L Mannaerts; Johan Smitz; H Coelingh Bennink; A Van Steirteghem
Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens.
Human reproduction (Oxford, England) 1994;9(6):1064-9.
1993: Paul Devroey; Bernadette M J L Mannaerts; Johan Smitz; H Coelingh Bennink; A Van Steirteghem
First established pregnancy and birth after ovarian stimulation with recombinant human follicle stimulating hormone (Org 32489).
Human reproduction (Oxford, England) 1993;8(6):863-5.
1993: Zeev Shoham; Bernadette M J L Mannaerts; V Insler; H Coelingh-Bennink
Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism.
Fertility and sterility 1993;59(4):738-42.
1993: Bernadette M J L Mannaerts; Zeev Shoham; D Schoot; P Bouchard; J Harlin; Bart CJM Fauser; H Jacobs; F Rombout; H Coelingh Bennink
Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers.
Fertility and sterility 1993;59(1):108-14.
1992: Paul Devroey; A Van Steirteghem; Bernadette M J L Mannaerts; H Coelingh Bennink
First singleton term birth after ovarian superovulation with rhFSH.
Lancet 1992;340(8827):1108-9.
1992: D C Schoot; H J Coelingh Bennink; Bernadette M J L Mannaerts; S W Lamberts; P Bouchard; Bart CJM Fauser
Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
The Journal of clinical endocrinology and metabolism 1992;74(6):1471-3.
1992: Paul Devroey; A van Steirteghem; Bernadette M J L Mannaerts; H C Bennink
Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH.
Lancet 1992;339(8802):1170.